Edwards Lifesciences Corp (NYSE: EW) is -7.93% lower on its value in year-to-date trading and has touched a low of $58.93 and a high of $96.12 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The EW stock was last observed hovering at around $70.53 in the last trading session, with the day’s loss setting it -0.33%.
Currently trading at $70.20, the stock is 2.12% and 3.04% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 5.71 million and changing -0.47% at the moment leaves the stock -11.34% off its SMA200. EW registered 2.69% gain for a year compared to 6-month loss of -19.69%. The firm has a 50-day simple moving average (SMA 50) of $68.07 and a 200-day simple moving average (SMA200) of $79.26185.
The stock witnessed a 3.94% gain in the last 1 month and extending the period to 3 months gives it a 1.84%, and is -1.50% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.88% over the week and 2.46% over the month.
Edwards Lifesciences Corp (EW) has around 19800 employees, a market worth around $41.40B and $5.87B in sales. Current P/E ratio is 10.13 and Fwd P/E is 28.71. Profit margin for the company is 70.82%. Distance from 52-week low is 19.12% and -26.97% from its 52-week high. The company has generated returns on investments over the last 12 months (40.66%).
with sales reaching $1.37B over the same period.The EPS is expected to grow by 2.53% this year, but quarterly earnings will post -2.85% year-over-year. Quarterly sales are estimated to shrink -11.01% in year-over-year returns.
Edwards Lifesciences Corp (EW) Top Institutional Holders
1758.0 institutions hold shares in Edwards Lifesciences Corp (EW), with institutional investors hold 86.73% of the company’s shares. The shares outstanding are 589.80M, and float is at 579.77M with Short Float at 1.18%. Institutions hold 85.94% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 53.58 million shares valued at $4.95 billion. The investor’s holdings represent 8.9056% of the EW Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 50.98 million shares valued at $4.71 billion to account for 8.4733 of the shares outstanding. The other top investors are STATE STREET CORP which holds 26.01 million shares representing 4.3233% and valued at over $2.4 billion, while ALLIANCEBERNSTEIN L.P. holds 3.3812 of the shares totaling 20.34 million with a market value of $1.88 billion.
Edwards Lifesciences Corp (EW) Insider Activity
The most recent transaction is an insider sale by BOBO DONALD E JR, the company’s CVP,Strategy/Corp Development. SEC filings show that BOBO DONALD E JR sold 5,000 shares of the company’s common stock on Nov 13 ’24 at a price of $65.57 per share for a total of $0.33 million. Following the sale, the insider now owns 46936.0 shares.
Still, SEC filings show that on Nov 05 ’24, Wood Larry L (Global President TAVR & Surg) disposed off 25,000 shares at an average price of $65.91 for $1.65 million. The insider now directly holds 198,526 shares of Edwards Lifesciences Corp (EW).
